[Vigency of lithium treatment].
Vieta
Eduard
E
Cruz
Nuria
N
Sánchez-Moreno
José
J
D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D018849:Controlled Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D000077213:Lamotrigine; D018020:Lithium Compounds / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D000077152:Olanzapine; D000077236:Topiramate; D014227:Triazines / Q000627:therapeutic use
D014150:Antipsychotic Agents; D018020:Lithium Compounds; D018696:Neuroprotective Agents; D014227:Triazines; D000077236:Topiramate; D001569:Benzodiazepines; D005632:Fructose; D000077152:Olanzapine; D000077213:Lamotrigine